{
    "title": "To amend the Controlled Substances Act to improve detection of the fraudulent abuse of prescriptions to obtain controlled substances in schedule II or III, and for other purposes.",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Fraudulent Prescription Prevention \nAct of 2011''.\n\nSEC. 2. FRAUDULENT PRESCRIPTION PREVENTION.\n\n    (a) In General.--Section 303 of the Controlled Substances Act (21 \nU.S.C. 823) is amended by adding at the end the following:\n    ``(i) Fraudulent Prescription Prevention.--\n            ``(1) Registration requirement.--The Attorney General may \n        not register a practitioner to dispense, or conduct research \n        with, a controlled substance in schedule II or III unless the \n        practitioner agrees to comply with the requirements of this \n        subsection.\n            ``(2) Reporting applicable to prescribing.--\n                    ``(A) In general.--At the time of prescribing a \n                controlled substance in schedule II or III, a \n                practitioner shall, by means of the web portal under \n                paragraph (4), submit the following information to the \n                Attorney General:\n                            ``(i) The name, date of birth, and address \n                        of the patient.\n                            ``(ii) The date and time of the \n                        prescription.\n                            ``(iii) The name and amount of the \n                        substance prescribed.\n                            ``(iv) The practitioner's Drug Enforcement \n                        Administration registration number.\n                            ``(v) The practitioner's contact \n                        information.\n                            ``(vi) If applicable, the prescription pad \n                        number.\n                    ``(B) Exceptions.--\n                            ``(i) Medical emergency situation.--\n                        Subparagraph (A) does not apply if the \n                        practitioner is prescribing a controlled \n                        substance in a medical emergency situation.\n                            ``(ii) Inconvenience.--If a practitioner \n                        does not have access to the web portal under \n                        paragraph (4) at the time of prescribing a \n                        controlled substance, the practitioner may make \n                        the submissions required by subparagraph (A) up \n                        to 7 days after the time of such prescribing.\n            ``(3) Reporting applicable to dispensing.--\n                    ``(A) In general.--Before dispensing a controlled \n                substance in schedule II or III, a practitioner shall, \n                by means of the web portal under paragraph (4), submit \n                the following information to the Attorney General:\n                            ``(i) Each item of information required to \n                        be reported under paragraph (2) in connection \n                        with prescribing the substance.\n                            ``(ii) The name, date of birth, and address \n                        of the purchaser of the substance.\n                            ``(iii) The date and time of the dispensing \n                        of the substance.\n                            ``(iv) The name and amount of the substance \n                        being dispensed.\n                            ``(v) Whether the dispensing constitutes a \n                        refill of a prescription.\n                            ``(vi) The practitioner's Drug Enforcement \n                        Administration registration number.\n                            ``(vii) The practitioner's contact \n                        information.\n                    ``(B) Declining to dispense.--At the time of \n                declining to dispense a controlled substance in \n                schedule II or III, a practitioner shall, by means of \n                the web portal under paragraph (4), submit the \n                following information to the Attorney General:\n                            ``(i) To the extent feasible, each item of \n                        information that would have been required to be \n                        reported under subparagraph (A) if the \n                        substance had been dispensed.\n                            ``(ii) Any reason to suspect that the \n                        individual attempting to purchase the substance \n                        was acting pursuant to fraud.\n            ``(4) Web portal.--The Attorney General shall establish and \n        maintain a web portal that--\n                    ``(A) allows a practitioner to submit information \n                to the Attorney General in accordance with paragraph \n                (2) or (3), as applicable; and\n                    ``(B) at the time of such submission, communicates \n                an alert to the practitioner if--\n                            ``(i) the patient or purchaser has \n                        repeatedly refilled the same prescription or \n                        prescriptions for the same controlled \n                        substance;\n                            ``(ii) the patient or purchaser has \n                        attempted to obtain or fill the same \n                        prescription or multiple prescriptions for the \n                        same controlled substance within the preceding \n                        30 days;\n                            ``(iii) the patient or purchaser has a \n                        history of purchasing controlled substances in \n                        schedule II or III at multiple pharmacies;\n                            ``(iv) the patient or purchaser has a \n                        history of purchasing such controlled \n                        substances in multiple States;\n                            ``(v) the purchaser is attempting to \n                        purchase a controlled substance using a \n                        prescription pad number that has been reported \n                        as missing or stolen; or\n                            ``(vi) any other circumstance exists that, \n                        as determined by the Attorney General, \n                        indicates an increased possibility that the \n                        patient or purchaser is attempting to \n                        unlawfully divert or misuse a controlled \n                        substance.\n            ``(5) Database.--The Attorney General shall establish and \n        maintain a database containing the information reported under \n        paragraphs (2) and (3).\n            ``(6) Disclosure of information.--The Attorney General may \n        disclose the information reported under paragraphs (2) and (3) \n        only as follows:\n                    ``(A) The Attorney General may make such \n                disclosures as may be necessary in order to communicate \n                alerts to practitioners under paragraph (4)(B).\n                    ``(B) The Attorney General may disclose information \n                reported under paragraph (2) or (3) to any local, \n                State, or Federal law enforcement, narcotics control, \n                licensure, disciplinary, or program authority who \n                certifies that the information is related to an \n                individual investigation or proceeding involving the \n                unlawful diversion or misuse of a controlled substance \n                in schedule II or III, and such information will \n                further the purpose of the investigation or assist in \n                the proceeding.\n                    ``(C) The Attorney General may, on request, \n                disclose information reported under paragraph (2) or \n                (3), or any summary or analysis thereof, to any person \n                or agency if--\n                            ``(i) the information, summary, or analysis \n                        is not individually identifiable; and\n                            ``(ii) the person or agency requesting the \n                        information, summary, or analysis provides \n                        satisfactory assurances that it will be used \n                        for research.\n            ``(7) Funding.--The only amounts authorized to be \n        appropriated to carry out this subsection are amounts in the \n        Diversion Control Fee Account established by section 111(b) of \n        the Departments of Commerce, Justice, and State, the Judiciary, \n        and Related Agencies Appropriations Act, 1993 (Public Law 102-\n        395).''.\n    (b) Applicability Date.--Paragraphs (1), (2), and (3) of section \n303(i) of the Controlled Substances Act, as added by subsection (a), \napply beginning on the date on which the Attorney General publishes in \nthe Federal Register a determination that the web portal and database \nrequired by paragraphs (4) and (5) of such section are fully \noperational."
}